Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma

18 Sept 2012

Abstract excerpt

BACKGROUND: Intra-arterial (i.a.) chemotherapy has more risks of procedural complications in neonates and young infants. For these reasons, we have developed a strategy of bridge intravenous single agent chemotherapy to postpone i.a. chemotherapy in these children PROCEDURE: Neonates and young infants with retinoblastoma who required chemotherapy were treated with systemic carboplatin chemotherapy (18.7 mg/kg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Metastases and Treatment
Share to Corneal Surgery and Treatments
Share to Ocular Oncology and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23028521
DOI: 10.1371/journal.pone.0044322

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with RetinoblastomaPMID 23028521Read ↗

Retinoblastoma in the perinatal and neonatal child.Semantic proximity Read ↗

Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).Semantic proximity Read ↗

A phase II trial of carboplatin for intraocular retinoblastomaSemantic proximity Read ↗

A 10‐year experience of outcome in chemotherapy‐treated hereditary retinoblastomaSemantic proximity Read ↗

Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries – Can we break the barriers?Semantic proximity Read ↗

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM studySemantic proximity Read ↗

Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.Semantic proximity Read ↗

Histopathologic Observations After Intra-arterial Chemotherapy for RetinoblastomaSemantic proximity Read ↗

Carboplatin-Associated Ototoxicity in Children With RetinoblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.